|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest bearing deposits in banks | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Loans held for sale, at fair value (amortized cost $17,000 at March 31, 2024) | ||||||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $0 (fair values of $15,122 at June 30, 2026 and $16,744 at December 31, 2025) | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $3,576 at June 30, 2026 and $3,440 at December 31, 2025 | ||||||||||||||||||||
| Net investment in direct financing leases | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Foreclosed assets | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Restricted investments carried at cost | ||||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Financial derivative | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Noninterest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from Federal Home Loan Bank (FHLB) | ||||||||||||||||||||
| Financial derivative | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, $0.01 par value, 19,000,000 shares authorized, 3,365,468 issued and 2,872,727 outstanding at June 30, 2026 and 3,366,516 issued and 2,887,275 outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Unearned Employee Stock Ownership Program (ESOP) shares, at cost | ||||||||||||||||||||
| Treasury stock, at cost (492,741 shares at June 30, 2026 and 479,241 shares at December 31, 2025) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
